Jon L. Collins

13.3k citations

71 papers · 10.4k indexed · 6 hit papers · h-index 41

Impact in

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
Biochemistry top 0.2%

Papers in

Pharmacology 10
- Pharmacogenetics and Drug Metabolism 9
Oncology 24
- Drug Transport and Resistance Mechanisms 24

Co-authors: Timothy M. Willson Steven A. Kliewer Linda B. Moore Peter Tontonoz Bryan Goodwin Derek J. Parks Michael A. Watson Millard H. Lambert
Journals: Journal of Biological Chemistry (9 papers)Journal of Medicinal Chemistry (7 papers)Proceedings of the National Academy of Sciences (6 papers)The Journal of Organic Chemistry (5 papers)Molecular Endocrinology (4 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Jon L. Collins

71 papers receiving 10.2k citations

Hit Papers

6 papers align trajectories log scale

ApoE Promotes the Proteolytic Degradation of Aβ 2008 · 716 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Neuron
2002 Proceedings of the National Academy of Sciences
2002 Journal of Biological Chemistry
2001 Science
2000 Proceedings of the National Academy of Sciences
2000 Journal of Biological Chemistry

Peers

Countries citing papers authored by Jon L. Collins

Since Specialization

Citations

This map shows the geographic impact of Jon L. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon L. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon L. Collins more than expected).

Fields of papers citing papers by Jon L. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon L. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon L. Collins. The network helps show where Jon L. Collins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jon L. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jon L. Collins Line = papers co-authored together Jon L. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular Determinants of Affinity and Isoform Selectivity in Protein─Small Molecule Hybrid Inhibitors of Carbonic Anhydrase Bioconjugate Chemistry ·Salina Torres, Chia‐Wei Lan, R. W. Butterfield, M. Hatch, Taki Can Metin Mustafa Kesici Davut Kodaş, Jon L. Collins, Benjamin J. Hackel	2025	1
2	Ube3a unsilencer for the potential treatment of Angelman syndrome Nature Communications ·Viktor Dyk, Kouassi Maxime Bohoussou, Hoinsoudé Segniagbeto, Linghan Xiong, Kiran R. Bettadapur, Lun-hua Weng, Mario J. Cachia, Justin Cotney, Quankun Xu, Jon L. Collins, Stormy J. Chamberlain, Hyeong-Min Lee, Jeffrey Aubé, Benjamin D. Philpot	2024	9
3	Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120) Bioorganic & Medicinal Chemistry Letters ·Steven M. Sparks, Grace Chen, Jon L. Collins, Dana P. Danger, Mo qingyi, Channa Jayawickreme, Stephen Jenkinson, Christopher P. Laudeman, M. Anthony Leesnitzer, Xi Liang, Patrick Maloney, Charlotte S. Tamayo-Urbina, Levin Ai, Nan Pang, Thomas J. Rimele, Chong Lian, James M. Way, Sean Ross	2014	94
4	Liver X Receptor Protects against Liver Injury in Sepsis Caused by Rodent Cecal Ligation and Puncture Surgical Infections ·Cynthia Nojimoto, Qing-xuan ZENG, Maria K. Dahle, Knut R. Steffensen, Christoph Thiemermann, Irshad H. Chaudry, Finn P. Reinholt, Jon L. Collins, Hilde I. Nebb, Ansgar O. Aasen, Jan-Ακε Gustafsson, Jacob E. Wang	2011	20
5	Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats Journal of Pharmacology and Experimental Therapeutics ·Lihong Chen, Judi A. McNulty, Don L. Anderson, Yaping Liu, Suyu Li, Sarah Bullard, Jon L. Collins, Anthony L. Handlon, Gourav Bhansali, Piskunov Vs, David W. Murray, C. R. Crowell, David Krull, 正彬安川, Elena Kleymenova, Katja Remlinger, Andrew Young, Xiaozhou Yao	2010	66
6	LIVER X RECEPTOR AGONIST GW3965 DOSE-DEPENDENTLY REGULATES LPS-MEDIATED LIVER INJURY AND MODULATES POSTTRANSCRIPTIONAL TNF-α PRODUCTION AND P38 MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION IN LIVER MACROPHAGES Shock ·Cynthia Nojimoto, Maria K. Dahle, Knut R. Steffensen, Finn P. Reinholt, Jon L. Collins, Christoph Thiemermann, Ansgar O. Aasen, Jan-Ακε Gustafsson, Jacob E. Wang	2009	37
7	Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth The Journal of Immunology ·Mark A. Birrell, Jorge De Alba, Matthew C. Catley, Elizabeth Hardaker, Sissie Wong, Michael P. Collins, Deborah Clarke, Stuart Farrow, Timothy M. Willson, Jon L. Collins, Maria G. Belvisi	2008	23
8	ApoE Promotes the Proteolytic Degradation of Aβ Neuron ·Qingguang Jiang, Willard F. Reese, Shweta Mandrekar, Brandy Wilkinson, Paige E. Cramer, Noam Zelcer, Karen M. Mann, Bruce T. Lamb, Timothy M. Willson, Jon L. Collins, Jill Richardson, Jonathan D. Smith, Thomas A. Comery, David Riddell, David M. Holtzman, Peter Tontonoz, Gary E. Landreth Hit paper breakdown →	2008	716
9	LIVER X RECEPTOR IS A KEY REGULATOR OF CYTOKINE RELEASE IN HUMAN MONOCYTES Shock ·Anders Eivind Myhre, D. Rizzo, Maria K. Dahle, Margareth V. Tamburstuen, Ståle Petter Lyngstadaas, Jon L. Collins, Simon J. Foster, Christoph Thiemermann, Ansgar O. Aasen, Jacob E. Wang	2008	38
10	Selective Partial Agonism of Liver X Receptor α Is Related to Differential Corepressor Recruitment Molecular Endocrinology ·Gil Fuentetaja, Jenny Bartlett-Prescott, David J. Steger, Shree Joshi, C.T Lee, Jon L. Collins, William J. Zuercher, Timothy M. Willson, Max Walker, Michael Jaye, Mitchell A. Lazar	2008	26
11	Recent Advances in Liver X Receptor Biology and Chemistry Current Topics in Medicinal Chemistry ·Bryan Goodwin, William J. Zuercher, Jon L. Collins	2008	27
12	Novel Role for the Liver X Nuclear Receptor in the Suppression of Lung Inflammatory Responses Journal of Biological Chemistry ·Mark A. Birrell, Matthew C. Catley, Elizabeth Hardaker, Sissie Wong, Timothy M. Willson, Kerryn McCluskie, Thomas B. Leonard, Stuart Farrow, Jon L. Collins, Saleem Haj‐Yahia, Maria G. Belvisi	2007	53
13	The Nuclear Receptor Superfamily and Drug Discovery ChemMedChem ·John T. Moore, Jon L. Collins, Kenneth H. Pearce	2006	116
14	Crystal structure of the PXR–T1317 complex provides a scaffold to examine the potential for receptor antagonism Bioorganic & Medicinal Chemistry ·Yu Xue, Esther Y. Chao, William J. Zuercher, Timothy M. Willson, Jon L. Collins, Matthew R. Redinbo	2006	105
15	Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRγ Bioorganic & Medicinal Chemistry Letters ·Esther Y. Chao, Jon L. Collins, Stéphanie Gaillard, Aaron B. Miller, Liping Wang, Lisa A. Orband‐Miller, Robert T. Nolte, Donald P. McDonnell, Timothy M. Willson, William J. Zuercher	2005	79
16	X-ray Crystal Structure of the Liver X Receptor β Ligand Binding Domain Journal of Biological Chemistry ·Shawn P. Williams, Randy K. Bledsoe, Jon L. Collins, Sharon Boggs, Millard H. Lambert, Ann B. Miller, John T. Moore, David D. McKee, Linda B. Moore, Jason A. Nichols, Derek J. Parks, Roser Mascaró Talaya, Bruce Wisely, Timothy M. Willson	2003	170
17	Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition of Inflammation and Primary Cytokine Production Journal of Investigative Dermatology ·Ashley J. Fowler, Mary Sheu, Matthias Schmuth, Jack Kao, Opeyemi Adebola Adetunji Funmilayo Dorcas Onajobi, Linda D. Rhein, Jon L. Collins, Timothy M. Willson, David J. Mangelsdorf, Peter M. Elias, Kenneth R. Feingold	2003	195
18	Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes Journal of Biological Chemistry ·Jodi M. Maglich, Derek J. Parks, Linda B. Moore, Jon L. Collins, Bryan Goodwin, Andrew N. Billin, Ni Komang Putri Rahayu, Steven A. Kliewer, Millard H. Lambert, Timothy M. Willson, John T. Moore	2003	351
19	Sterol Regulatory Element-binding Protein-1c Is Responsible for Cholesterol Regulation of Ileal Bile Acid-binding Protein Gene in Vivo Journal of Biological Chemistry ·Isabelle Zaghini, Jean‐François Landrier, Jacques Grober, Stéphane Krief, Stacey A. Jones, Marie-Claude Monnot, Isabelle Lefrère, Michael A. Watson, Jon L. Collins, Hiroshi Fujii, Philippe Besnard	2002	29
20	Synthetic studies on quassinoids: total synthesis of (.+-.)-shinjulactone C The Journal of Organic Chemistry ·Jon L. Collins, Paul A. Grieco, Raymond S. Gross	1990	16

About Jon L. Collins

Jon L. Collins is a scholar working on Pharmacology, Oncology, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 71 papers that have together received 10.4k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (27 papers), Drug Transport and Resistance Mechanisms (24 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Pharmacogenetics and Drug Metabolism (9 papers), Estrogen and related hormone effects (9 papers), Phytochemical compounds biological activities (7 papers), Hormonal Regulation and Hypertension (7 papers) and Multicomponent Synthesis of Heterocycles (5 papers). The work is most often cited by research in Pharmacology (2.1k citations), Biochemistry (911 citations), Oncology (2.9k citations), Endocrinology, Diabetes and Metabolism (1.6k citations) and Surgery (3.5k citations). Jon L. Collins has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Timothy M. Willson, Steven A. Kliewer, Linda B. Moore, Peter Tontonoz, Bryan Goodwin, Derek J. Parks, Michael A. Watson, Millard H. Lambert, Sean B. Joseph and Bryan Laffitte. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, The Journal of Organic Chemistry and Molecular Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact